RRM1
Ribonucleoside-diphosphate reductase large subunit
Also known as: RIR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23921
- Gene
- RRM1
- Ensembl
- ENSG00000167325
- Chromosome
- 11
- Canonical length
- 792 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Centriolar satellite,Basal body,Cytosol
OverviewNCBI Gene
This gene encodes the large and catalytic subunit of ribonucleotide reductase, an enzyme essential for the conversion of ribonucleotides into deoxyribonucleotides. A pool of available deoxyribonucleotides is important for DNA replication during S phase of the cell cycle as well as multiple DNA repair processes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
792 residues, UniProt reviewed canonical sequence.
>P23921|RRM1
1 MHVIKRDGRQ ERVMFDKITS RIQKLCYGLN MDFVDPAQIT MKVIQGLYSG VTTVELDTLA
61 AETAATLTTK HPDYAILAAR IAVSNLHKET KKVFSDVMED LYNYINPHNG KHSPMVAKST
121 LDIVLANKDR LNSAIIYDRD FSYNYFGFKT LERSYLLKIN GKVAERPQHM LMRVSVGIHK
181 EDIDAAIETY NLLSERWFTH ASPTLFNAGT NRPQLSSCFL LSMKDDSIEG IYDTLKQCAL
241 ISKSAGGIGV AVSCIRATGS YIAGTNGNSN GLVPMLRVYN NTARYVDQGG NKRPGAFAIY
301 LEPWHLDIFE FLDLKKNTGK EEQRARDLFF ALWIPDLFMK RVETNQDWSL MCPNECPGLD
361 EVWGEEFEKL YASYEKQGRV RKVVKAQQLW YAIIESQTET GTPYMLYKDS CNRKSNQQNL
421 GTIKCSNLCT EIVEYTSKDE VAVCNLASLA LNMYVTSEHT YDFKKLAEVT KVVVRNLNKI
481 IDINYYPVPE ACLSNKRHRP IGIGVQGLAD AFILMRYPFE SAEAQLLNKQ IFETIYYGAL
541 EASCDLAKEQ GPYETYEGSP VSKGILQYDM WNVTPTDLWD WKVLKEKIAK YGIRNSLLIA
601 PMPTASTAQI LGNNESIEPY TSNIYTRRVL SGEFQIVNPH LLKDLTERGL WHEEMKNQII
661 ACNGSIQSIP EIPDDLKQLY KTVWEISQKT VLKMAAERGA FIDQSQSLNI HIAEPNYGKL
721 TSMHFYGWKQ GLKTGMYYLR TRPAANPIQF TLNKEKLKDK EKVSKEEEEK ERNTAAMVCS
781 LENRDECLMC GSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RRM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- thymus: 53 nTPM
- tonsil: 42 nTPM
- skin: 34 nTPM
- lymph node: 32 nTPM
- bone marrow: 31 nTPM
- skeletal muscle: 28 nTPM
Single-cell type
- erythrocyte progenitors: 210 nCPM
- early primary spermatocytes: 168 nCPM
- monocyte progenitors: 148 nCPM
- neutrophil progenitors: 117 nCPM
- late spermatids: 108 nCPM
- megakaryocyte progenitors: 99 nCPM
Immune cell
- T-reg: 42 nTPM
- memory CD4 T-cell: 22 nTPM
- MAIT T-cell: 21 nTPM
- naive CD4 T-cell: 17 nTPM
- memory CD8 T-cell: 17 nTPM
- non-classical monocyte: 16 nTPM
Brain region
- cerebellum: 11 nTPM
- pons: 10 nTPM
- spinal cord: 9.4 nTPM
- white matter: 9.3 nTPM
- medulla oblongata: 9.1 nTPM
- hypothalamus: 8.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RRM1.
Disease | AllUniProt
Conditions RRM1 is implicated in, by any mechanism.
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 6 (PEOB6) MIM:620647
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 83 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6
- RRM1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.1
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.99
- DepMap mean gene effect
- -2.86
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 2'-deoxyribonucleotide biosynthetic process
- cell proliferation in forebrain
- deoxyribonucleotide biosynthetic process
- DNA repair
- DNA synthesis involved in DNA repair
- male gonad development
- mitochondrial DNA replication
- positive regulation of G0 to G1 transition
- positive regulation of G1/S transition of mitotic cell cycle
- positive regulation of G2/M transition of mitotic cell cycle
- protein heterotetramerization
- pyrimidine nucleobase metabolic process
- response to ionizing radiation
- retina development in camera-type eye
- ribonucleoside diphosphate metabolic process
Molecular functions
- ATP binding
- disordered domain specific binding
- identical protein binding
- ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor
- ribonucleoside-diphosphate reductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribonucleotide reductase large subunit, C-terminal
- ATP-cone domain
- Ribonucleotide reductase R1 subunit, N-terminal
- Ribonucleotide reductase, class I, alpha subunit, C-terminal
- Ribonucleotide reductase large subunit, N-terminal
- Ribonucleoside-diphosphate reductase large subunit
- Ribonucleotide reductase, all-alpha domain
- Ribonucleotide reductase, barrel domain
- ATP cone domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RRM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RRM1 as an antibody target. Whether an autoantibody or antibody against RRM1 could matter depends on whether native RRM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RRM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RRM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...